PARACRINE REGULATION OF ANGIOGENESIS BY FIBROBLASTS
成纤维细胞对血管生成的旁分泌调节
基本信息
- 批准号:2230040
- 负责人:
- 金额:$ 23.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 2000-02-29
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay angiogenesis antisense nucleic acid basement membrane cell growth regulation collagen fibroblast growth factor fibroblasts fibronectins immunocytochemistry immunoelectron microscopy immunoprecipitation laboratory rat laminin muscle cells neutralizing antibody northern blottings paracrine platelet derived growth factor polymerase chain reaction tissue /cell culture vascular endothelium western blottings
项目摘要
Angiogenesis, i.e. the formation of blood vessels by endothelial cells,
plays a critical role in wound healing and in pathologic processes such as
neoplastic growth, rheumatoid arthritis, diabetic retinopathy, and
atherosclerosis. The long term goal of these studies is to elucidate the
molecular mechanisms of angiogenesis and to facilitate the treatment of
angiogenesis-dependent disorders. We have developed a serum-free in vitro
model of angiogenesis which is based on the capacity of rat aorta rings to
generate microvessels in collagen gels. Angiogenesis in this model is
regulated by endogenous basic fibroblast growth factor (bFGF) and
platelet-derived growth factor (PDGF). We also postulate a role for
vascular endothelial growth factor (VEGF) based on its potent stimulatory
effect on the system. Our hypothesis is that aortic fibroblasts stimulated
by bFGF and PDGF promote the formation of microvessels by producing
heparin-binding growth factors including VEGF. We also hypothesize that
fibroblasts stabilize microvessels by promoting the perivascular
deposition of basement membrane. Using a serum-free co-culture model
recently developed in our laboratory we will evaluate the effect of
fibroblasts on the proliferative and vasoformative response of endothelial
cells to bFGF and PDGF. We will also investigate the inhibitory effects on
rat aortic angiogenesis of neutralizing antibodies against these growth
factors. Immunoprecipitation studies together with light and electron
immunohistochemical analysis will evaluate how fibroblasts influence the
perivascular production, deposition, and distribution of fibronectin,
laminin, and type IV collagen, which are components of the basement
membrane. The stabilizing effects of these molecules on the microvessels
will be also evaluated. The production of VEGF by fibroblasts and by
aortic cultures at different stages of angiogenesis will be studied by
Western blotting, Northern blotting, reverse transcriptase-polymerase
chain reaction (RT-PCR), and RNAase protection assay. The expression of
the endothelial VEGF receptor during angiogenesis will be investigated by
affinity labeling studies, RT-PCR, and RNAase protection assay. The
function of endogenous VEGF in the rat aorta model will be inhibited with
anti-VEGF antibodies and antisense oligonucleotides. By studying how
fibroblasts regulate angiogenesis we will gain insight into the mechanisms
of angiogenesis-dependent disorders which are often characterized by a
combination of fibroblastic and vascular proliferation.
血管生成,即由内皮细胞形成血管,
在伤口愈合和病理过程中起关键作用
肿瘤生长,类风湿关节炎,糖尿病性视网膜病和
动脉粥样硬化。这些研究的长期目标是阐明
血管生成的分子机制,并促进
血管生成依赖性疾病。我们已经开发了一种无血清体外
血管生成模型基于大鼠主动脉环的能力
在胶原蛋白凝胶中产生微丝。该模型中的血管生成是
由内源性基本成纤维细胞生长因子(BFGF)和
血小板衍生的生长因子(PDGF)。我们还假设了一个角色
基于其有效刺激的血管内皮生长因子(VEGF)
对系统的影响。我们的假设是刺激主动脉成纤维细胞
通过BFGF和PDGF通过产生生产来促进微血管的形成
包括VEGF在内的肝素结合增长因素。 我们还假设
成纤维细胞通过促进血管来稳定微血管
地下膜的沉积。使用无血清共培养模型
最近在我们的实验室开发的,我们将评估
内皮的增生和血管生成反应的成纤维细胞
细胞到BFGF和PDGF。我们还将研究对
对这些生长的中和抗体的大鼠主动脉血管生成
因素。免疫沉淀研究与光和电子
免疫组织化学分析将评估成纤维细胞如何影响
纤连蛋白的血管周围产生,沉积和分布,
层粘连蛋白和IV型胶原蛋白,它们是地下室的组成部分
膜。这些分子对微血管的稳定作用
还将评估。通过成纤维细胞生产VEGF和
在不同阶段的血管生成阶段的主动脉培养会通过
蛋白质印迹,北印迹,逆转录酶 - 聚合酶
链反应(RT-PCR)和RNAase保护测定法。表达
血管生成过程中的内皮VEGF受体将通过
亲和力标记研究,RT-PCR和RNAase保护分析。这
内源性VEGF在大鼠主动脉模型中的功能将被抑制
抗VEGF抗体和反义寡核苷酸。通过研究如何
成纤维细胞调节血管生成我们将深入了解机制
血管生成依赖性疾病的特征是
成纤维细胞和血管增殖的组合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERTO NICOSIA其他文献
ROBERTO NICOSIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERTO NICOSIA', 18)}}的其他基金
PARACRINE REGULATION OF ANGIOGENESIS BY MURAL CELLS
壁细胞对血管生成的旁分泌调节
- 批准号:
6625639 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
PARACRINE REGULATION OF ANGIOGENESIS BY MURAL CELLS
壁细胞对血管生成的旁分泌调节
- 批准号:
7568229 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
PARACRINE REGULATION OF ANGIOGENESIS BY FIBROBLASTS
成纤维细胞对血管生成的旁分泌调节
- 批准号:
2230041 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
PARACRINE REGULATION OF ANGIOGENESIS BY MURAL CELLS
壁细胞对血管生成的旁分泌调节
- 批准号:
6873025 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
PARACRINE REGULATION OF ANGIOGENESIS BY MURAL CELLS
壁细胞对血管生成的旁分泌调节
- 批准号:
6477812 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
PARACRINE REGULATION OF ANGIOGENESIS BY FIBROBLASTS
成纤维细胞对血管生成的旁分泌调节
- 批准号:
2378826 - 财政年份:1995
- 资助金额:
$ 23.34万 - 项目类别:
相似国自然基金
基于Elabela-APJ轴探讨健脾化癥饮通过逆转EMT进而抑制胃癌血管生成拟态形成的机制研究
- 批准号:82305102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Nrf1/2调控ACER2介导的SphK-S1P-S1PR通路在肝癌血管生成中的机制研究
- 批准号:82302988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SFN-RAB7互作通过溶酶体自噬减少外泌体传递LncRNA H19调控肿瘤血管生成和鼻咽癌恶性进展
- 批准号:82360528
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
术藤合剂通过USP8介导的HIF-1α去泛素化调控血管生成拟态抑制结直肠癌侵袭转移的机制研究
- 批准号:82305330
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
兼具抑制内源性耗氧及抗血管生成水凝胶体系的优化及其逆转口腔鳞癌光动力乏氧抵抗的效果及机制研究
- 批准号:82373394
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
LOSS OF TUMORGENICITY INDUCED BY TGF-B ANTISENSE GENE
TGF-B 反义基因诱导的致瘤性丧失
- 批准号:
2700652 - 财政年份:1997
- 资助金额:
$ 23.34万 - 项目类别: